Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.

Literature DB >> 23588317

The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.

O Gottesman¹, S A Scott, S B Ellis, C L Overby, A Ludtke, J-S Hulot, J Hall, K Chatani, K Myers, J L Kannry, E P Bottinger.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23588317 PMCID： PMC3720762 DOI： 10.1038/clpt.2013.72

Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875

× No keyword cloud information.

4 in total

1. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors: M V Relling; T E Klein
Journal: Clin Pharmacol Ther Date: 2011-01-26 Impact factor: 6.875

2. A roadmap for national action on clinical decision support.

Authors: Jerome A Osheroff; Jonathan M Teich; Blackford Middleton; Elaine B Steen; Adam Wright; Don E Detmer
Journal: J Am Med Inform Assoc Date: 2007-01-09 Impact factor: 4.497

3. Pharmacogenomics: "noninferiority" is sufficient for initial implementation.

Authors: R B Altman
Journal: Clin Pharmacol Ther Date: 2011-03 Impact factor: 6.875

Review 4. Personalizing medicine with clinical pharmacogenetics.

Authors: Stuart A Scott
Journal: Genet Med Date: 2011-12 Impact factor: 8.822

4 in total

70 in total

1. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.

Authors: A Owusu Obeng; T Kaszemacher; N S Abul-Husn; O Gottesman; A Vega; E Waite; K Myers; J Cho; E P Bottinger; S B Ellis; S A Scott
Journal: Clin Pharmacol Ther Date: 2016-08-18 Impact factor: 6.875

Review 2. The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors: Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal: Expert Opin Drug Metab Toxicol Date: 2015-07-14 Impact factor: 4.481

3. Development and validation of an electronic phenotyping algorithm for chronic kidney disease.

Authors: Girish N Nadkarni; Omri Gottesman; James G Linneman; Herbert Chase; Richard L Berg; Samira Farouk; Rajiv Nadukuru; Vaneet Lotay; Steve Ellis; George Hripcsak; Peggy Peissig; Chunhua Weng; Erwin P Bottinger
Journal: AMIA Annu Symp Proc Date: 2014-11-14

4. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.

Authors: Brian H Shirts; Joseph S Salama; Samuel J Aronson; Wendy K Chung; Stacy W Gray; Lucia A Hindorff; Gail P Jarvik; Sharon E Plon; Elena M Stoffel; Peter Z Tarczy-Hornoch; Eliezer M Van Allen; Karen E Weck; Christopher G Chute; Robert R Freimuth; Robert W Grundmeier; Andrea L Hartzler; Rongling Li; Peggy L Peissig; Josh F Peterson; Luke V Rasmussen; Justin B Starren; Marc S Williams; Casey L Overby
Journal: J Am Med Inform Assoc Date: 2015-07-03 Impact factor: 4.497

5. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.

Authors: Jai N Patel; Danielle Boselli; Elizabeth J Jandrisevits; Issam S Hamadeh; Ahmed Salem; Patrick Meadors; Declan Walsh
Journal: Support Care Cancer Date: 2021-03-24 Impact factor: 3.603

6. Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.

Authors: Carolyn R Rohrer Vitek; Noura S Abul-Husn; John J Connolly; Andrea L Hartzler; Terrie Kitchner; Josh F Peterson; Luke V Rasmussen; Maureen E Smith; Sarah Stallings; Marc S Williams; Wendy A Wolf; Cynthia A Prows
Journal: Pharmacogenomics Date: 2017-06-22 Impact factor: 2.533